Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 1945 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 


 
RENAL DATA FROM THE ARAB WORLD Table of Contents   
Year : 2008  |  Volume : 19  |  Issue : 5  |  Page : 825-830
Cancers after Renal Transplantation: Multicenter Experience


1 Unity of Organ Transplantation, Military Hospital of Tunis, Tunisia
2 Department of Nephrology, Charles Nicolle Hospital Tunis, Tunisia
3 Department of Nephrology, Hedi Chaker Hospital Sfax, Tunisia
4 Department of Nephrology, Fattouma Bourguiba Hospital Monastir, Tunisia
5 Department of Nephrology, Sahloul Hospital Sousse, Tunisia, Tunisia
6 Unity of Hemodialysis, Military Hospital of Tunis, Tunisia

Correspondence Address:
Kais Harzallah
Unity of Organ Transplantation, Military Hospital of Tunis
Tunisia
Login to access the Email id


PMID: 18711309

Rights and Permissions

Renal transplant recipients are at higher risk of certain tumors such as lymphomas and skin cancers and than the general and dialysis populations. We retrospectively studied the prevalence of tumors in adult renal transplant recipients in four Tunisian centers of transplantation in Tunis, Monsatir and Sfax from January 1986 to January 2005. The study included 36 patients; 19 men and 17 women with a mean age of 34.6 years (range from 18-54 years). The mean time since dialysis to transplantation was 43 months (6-131months). Maintenance therapy was based on calcineurin inhibitors (CNI) in 86 % of cases, on antimetabolites and corticosteroids in 100 % of cases. Anti-thymoglobulin was administered in a mean course of 12.4 days in 78 % of the patients. Acute rejection occurred in 25 cases and was treated with polyclonal or monoclonal antibodies on 40 % of cases. Incidence of cancer among our population was 7 % and occurred after a mean period of 54 months of transplantation (range from 4-160 months). Eighty three percent of the tumors were solid, and the rest were in the skin. Kaposi sarcoma formed 41.6 % and non-Hodgkin or Hodgkin lymphoma 27.7 % of the solid tumors, while spinocellular carcinoma formed 83% and basocellular carcinoma 17% of the skin tumors. Switching CNI to sirolimus in 8.3% cases was associated with a favorable outcome. Mortality was the outcome in 33.3% of the patients with cancer, while partial or complete regression of cancers was observed in 55.5% cases after decreasing the doses of the immunosuppressive medications. We conclude that post renal transplant cancer is mainly characterized by the predominance of Kaposi sarcoma favored by solar exposure and rigorously induced and maintained immunosuppression. Careful follow-up may results in early inter­vention and decrease mortality.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4865    
    Printed98    
    Emailed0    
    PDF Downloaded1336    
    Comments [Add]    
    Cited by others 7    

Recommend this journal